Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual

Journal of Neuro-Oncology

Volumn 41, Issue 3, 1999, Pages 247-254

  Onda, Kiyoshi ^a,b   Nagai, Shoichi ^a   Tanaka, Ryuichi ^a   Morii, Ken ^a   Yoshimura, Jun Ichi ^a   Tsumanuma, Itaru ^a   Kumanishi, Toshiro ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Niigata Neurosurgical Hospital   (Japan)

Author keywords

Cell line; Culture; Glioma; mRNA expression; Tumor suppressor genes

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CASE REPORT; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; GENE DELETION; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESSENGER RNA SYNTHESIS; NUDE MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN NEOPLASMS; CELL CULTURE TECHNIQUES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; KINETICS; MALE; MICE; MICE, NUDE; MIDDLE AGED; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032928163     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006172608019     Document Type: Article

References (34)

1. The Committee of Brain Tumor Registry of Japan: Special issue. Neurol Med Chir (Tokyo) 32: 391-417, 1992
2. Daumas-Duport C, ScheithauerB, O'Fallon J, Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152-2165, 1988
3. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. Springer-Verlag, 1993, ed 2, pp 11-14
4. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System. London, Edward Arnold, 1977, ed 4, pp 146-244
5. Hayashi Y, Yamashita J, Yamaguchi K: Timing and role of p53 gene mutation in the recurrence of glioma. Biochem Biophys Res Commun 180: 1145-1150, 1991
6. Koga H, Zhang SJ, Kumanishi T, Washiyama K, Ichikawa T, Tanaka R, Mukawa J: Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Acta Neuropathol 87: 225-232, 1994
7. Louis DN, von Deimling A, Chung RY, Rubio M-P, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52: 31-38, 1992
8. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K: Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313-1318, 1991
9. Zhang SJ, Feng XL, Koga H, Ichikawa T, Abe S, Kumanishi T: p53 gene mutations in pontine gliomas of juvenile onset. Biochem Biophys Res Commun 196: 851-857, 1993
10. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B: Deletion of p16 and p15 genes in brain tumors. Cancer Res 54: 6353-6358, 1994
11. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994
12. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994
13. Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321-6324, 1994
14. Onda K, Tanaka R, Washiyama K, Takeda N, Kumanishi T: Correlation of DNA ploidy and morphological features of human glioma cell cultures with the establishment of cell lines. Acta Neuropathol 76: 433-440, 1988
15. Harris M: Quantitative growth studies with chick myoblasts in glass substrate cultures. Growth 21: 149-166, 1957
16. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770, 1989
17. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427-428, 1991
18. Kumanishi T, Zhang SJ, Ichikawa T, Endo S, Washiyama K: Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions. Jpn J Cancer Res 87: 691-695, 1996
19. Zhang SJ, Endo S, Koga H, Ichikawa T, Feng XL, Onda K, Washiyama K, Kumanishi T: A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations. Jpn J Cancer Res 87: 900-907, 1996
20. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994
21. Usui H, Ichikawa T, Miyazaki Y, Nagai S, Kumanishi T: Isolation of cDNA clones of the rat mRNAs expressed preferentially in the prenatal stages of brain development. Develop Brain Res 97: 185-193, 1996
22. Bigner DD, Bigner SH, Pontén J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40: 201-229, 1981
23. Maunoury R: Establishment and characterization of 5 human cell lines derived from a series of 50 primary intracranial tumors. Acta Neuropathol 39: 33-41, 1977
24. Pontén J, Macintyre EH: Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74: 465-486, 1968
25. Rutka JT, Giblin JR, Dougherty DY, Liu HC, McCulloch JR, Bell CW, Stern RS, Wilson CB, Rosenblum ML: Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 75: 92-103, 1987
26. Studer A, de Tribolet N, Diserens AC, Gaide AC, Matthieu JM, Carrel S, Stavrou D: Characterization of four human malignant glioma cell lines. Acta Neuropathol 66: 208-217, 1985
27. Westermark B, Pontén J, Hugosson R: Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand 81: 791-805, 1973
28. Allalunis-Turner MJ, Barron GM, Day III RS, Dobler KD, Mirzayans R: Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134: 349-354, 1993
29. Eliyahu D, Michalovitz D, Oren M: Overproduction of p53 antigen makes established cells highly tumorigenic. Nature 316: 158-160, 1985
30. Venter DJ, Bevan KL, Ludwig RL, Riley TEW, Jat PS, Thomas DGT, Noble MD: Retinoblastoma gene deletions in human glioblastomas. Oncogene 6: 445-448, 1991
31. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis G, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275: 1943-1947, 1997
32. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Lignon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997
33. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ulrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144-147, 1985
34. Mørk SJ, Laerum OD: DNA distribution in human gliomas in vivo and in vitro. In: Laerum OD, Lindmo T, Thorud E (eds) Flow Cytometry IV. Universitetsforlaget, Oslo, pp 403-406